Skip to main content

Table 3 BAL microbiology results

From: Utility of bronchoalveolar lavage in the management of immunocompromised patients presenting with lung infiltrates

 

n (%)

Bacterial

 Total

43

  Mycobacterium tuberculosis

13 (30.2%)

  Pseudomonas aeruginosa

8 (18.6%)

  Klebsiella spp.

5 (11.6%)

  Enterococcus spp.

4 (9.3%)

  Stentotrophomonas maltophilia

4 (9.3%)

  Staphylococcus aureus

2 (4.7%)

  Acinetobacter baumannii

1 (2.3%)

  Escherichia coli

1 (2.3%)

  Mycobacterium abscessus

1 (2.3%)

  Mycobacterium avium

1 (2.3%)

  Nocardia sp.

1 (2.3%)

  Streptococcus pneumoniae

1 (2.3%)

  Streptococcus anginosus

1 (2.3%)

Fungal Microscopy/Culture

 Total

51

  Pneumocystis jirovecii

37 (72.5%)

  Aspergillus spp.

10 (19.6%)

  Cryptococcus spp.

3 (5.9%)

  Phaeoacremonium spp.

1 (2.0%)

Viral

 Total

64

  Cytomegalovirus

16 (25.0%)

  Rhinovirus

12 (18.8%)

  Coronavirus

9 (14.1%)

  Parainfluenza

9 (14.1%)

  Influenza

7 (10.9%)

  Respiratory syncytial virus

7 (10.9%)

  Adenovirus

3 (4.7%)

  Metapneumovirus

1 (1.6%)